A panel of advisers to the US Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson's COVID-19 vaccine for people aged 18 and older at least two months after the first dose.
US FDA advisers vote in favor of booster for J&J COVID-19 vaccine
By REUTERS
11/14/2024 01:19 AM
By REUTERS
11/14/2024 01:17 AM
By REUTERS
11/14/2024 01:13 AM
By REUTERS
11/13/2024 11:12 PM
By REUTERS
11/13/2024 10:24 PM
By WALLA! CULTURE
11/13/2024 09:08 PM
By REUTERS
11/13/2024 07:27 PM